Jan Borén
Jan Borén
Dept of Molecular and Clinical Medicine, University of Gothenburg, Sweden
Verified email at wlab.gu.se
TitleCited byYear
Heart disease and stroke statistics-2017 update: a report from the American Heart Association.
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, J Floyd, ...
circulation 135 (10), e146-e603, 2017
57022017
2016 ESC/EAS guidelines for the management of dyslipidaemias
AL Catapano, I Graham, G De Backer, O Wiklund, MJ Chapman, H Drexel, ...
European heart journal 37 (39), 2999-3058, 2016
16592016
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of …
BG Nordestgaard, MJ Chapman, SE Humphries, HN Ginsberg, L Masana, ...
European heart journal 34 (45), 3478-3490, 2013
15042013
Lipoprotein (a) as a cardiovascular risk factor: current status
BG Nordestgaard, MJ Chapman, K Ray, J Borén, F Andreotti, GF Watts, ...
European heart journal 31 (23), 2844-2853, 2010
12602010
Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications
I Tabas, KJ Williams, J Borén
Circulation 116 (16), 1832-1844, 2007
11332007
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
MJ Chapman, HN Ginsberg, P Amarenco, F Andreotti, J Borén, ...
European heart journal 32 (11), 1345-1361, 2011
10032011
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
K Skĺlén, M Gustafsson, EK Rydberg, LM Hultén, O Wiklund, TL Innerarity, ...
Nature 417 (6890), 750, 2002
9892002
Overproduction of very low–density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome
M Adiels, SO Olofsson, MR Taskinen, J Borén
Arteriosclerosis, thrombosis, and vascular biology 28 (7), 1225-1236, 2008
6842008
Overproduction of large VLDL particles is driven by increased liver fat content in man
M Adiels, MR Taskinen, C Packard, MJ Caslake, A Soro-Paavonen, ...
Diabetologia 49 (4), 755-765, 2006
5832006
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European …
BA Ference, HN Ginsberg, I Graham, KK Ray, CJ Packard, E Bruckert, ...
European heart journal 38 (32), 2459-2472, 2017
5132017
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on …
M Cuchel, E Bruckert, HN Ginsberg, FJ Raal, RD Santos, RA Hegele, ...
European heart journal 35 (32), 2146-2157, 2014
5022014
The gut microbiota modulates host energy and lipid metabolism in mice
VR Velagapudi, R Hezaveh, CS Reigstad, P Gopalacharyulu, L Yetukuri, ...
Journal of lipid research 51 (5), 1101-1112, 2010
3862010
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
A Wiegman, SS Gidding, GF Watts, MJ Chapman, HN Ginsberg, M Cuchel, ...
European heart journal 36 (36), 2425-2437, 2015
3592015
Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor …
J Borén, K Olin, I Lee, A Chait, TN Wight, TL Innerarity
The Journal of clinical investigation 101 (12), 2658-2664, 1998
3591998
SNARE proteins mediate fusion between cytosolic lipid droplets and are implicated in insulin sensitivity
P Boström, L Andersson, M Rutberg, J Perman, U Lidberg, BR Johansson, ...
Nature cell biology 9 (11), 1286, 2007
3282007
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
RA Hegele, HN Ginsberg, MJ Chapman, BG Nordestgaard, ...
The lancet Diabetes & endocrinology 2 (8), 655-666, 2014
2952014
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint …
BG Nordestgaard, A Langsted, S Mora, G Kolovou, H Baum, E Bruckert, ...
European heart journal 37 (25), 1944-1958, 2016
2912016
Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis
R Ricci, G Sumara, I Sumara, I Rozenberg, M Kurrer, A Akhmedov, ...
Science 306 (5701), 1558-1561, 2004
2832004
Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis
SO Olofsson, J Boren
Journal of internal medicine 258 (5), 395-410, 2005
2812005
Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease
H Gylling, J Plat, S Turley, HN Ginsberg, L Ellegĺrd, W Jessup, PJ Jones, ...
Atherosclerosis 232 (2), 346-360, 2014
2712014
The system can't perform the operation now. Try again later.
Articles 1–20